Biotech companies often face big hurdles when trying to take new discoveries from the lab to industrial production. 21st.BIO’s pilot plant gives innovators a practical way to scale up bioproduction with expert support and advanced equipment. This facility allows companies to test, optimise, and refine their processes before full-scale manufacturing.
The pilot plant focuses on the production of recombinant proteins and peptides, which are important for industries such as food, nutrition, and beverages. By offering access to precise fermentation and guidance from experienced specialists, 21st.BIO helps companies move from idea to reality more smoothly. Readers interested in the future of industrial biotech will find insights into how advanced pilot plants are shaping this field.
Pilot Plant Bioproduction at 21st.BIO
21st.BIO operates a biotech pilot plant specialising in scaling up bioproduction. The facility provides advanced support for transitioning from laboratory experiments to industrial-level manufacturing. Click here for more information.
Overview of Pilot Plant Capabilities
The pilot plant enables clients to upscale their biotech processes using state-of-the-art equipment and expert support. It is designed for flexibility, allowing different types of production including microbial fermentation and enzyme development.
This helps companies bridge the gap between research and full-scale production.
Services include process optimisation and technical guidance throughout the production stages. The facility can manage multiple projects and supports the development of innovative bio-based products. Customers benefit from shorter development times and reduced risk during scale-up.
Robust safety measures and quality controls are in place to ensure reliable results. The team has experience across various biotechnology fields, making the plant adaptable for a wide range of applications.
Bioprocess Scale-Up Solutions
Scaling a bioprocess from laboratory to industrial scale can be complex. At the pilot plant, a structured approach is used to support each step of the upscaling process, reducing technical and financial risks.
Key steps in scale-up include:
- Lab-scale process validation
- Pilot-scale optimisation
- Preparation for commercial production
The team assists with troubleshooting, process transfer, and technology adjustments. Their expertise helps improve process efficiency and yields. Pilot plant data is used to make informed decisions, resulting in faster time-to-market for new bioproducts.
The facility supports companies that need to test and refine their processes before moving to full-scale manufacturing. This approach enables clients to achieve consistent and scalable results.
Cutting-Edge Technologies and Facilities
The plant houses advanced bioreactors, automated control systems, and downstream processing equipment. These tools allow precise control over critical parameters such as pH, temperature, and oxygen levels, improving reproducibility and product quality.
Specialised units support a variety of bioproduction methods. The facility is equipped for both continuous and batch processes. Automation and data logging systems streamline process monitoring and reporting.
Expert guidance and access to modern resources allow clients to optimise operations at every step. The pilot facility is designed to support innovative biotech solutions with cutting-edge infrastructure.